Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
METHOD FOR PREPARING CALCIUM RECEPTOR-ACTIVE COMPOSITION, AND USE THEREOF
Document Type and Number:
Japanese Patent JP2001220356
Kind Code:
A
Abstract:

To provide the design, development, composition and use of a new calcimimetic molecule capable of acting on extracellular calcium ion on the cell by a method mimicking the calcium ion, a calcilytic inhibiting the activity of the intercellular calcium ion on the cell, and a method for producing the same and identification thereof.

This method for producing medicinal composition for treating a patient suffering from a disease characterized by an abnormal level of calcium ion, PTH, inositol triphosphate, calcitonin or diacylglycerol comprises a step for mixing a compound with a pharmaceutically acceptable carrier, and the compound is characterized in that when carrying out the assay by using the assay for measuring an intramolecular free calcium ion in an epidermal parathyroid cell, the compound can cause the increase of the intracellular free Ca2+ concentration by ≤5 μM EC50.


Inventors:
NEMETH EDWARD F
WAGENEN BRADFORD C VAN
BALANDRIN MANUEL F
Application Number:
JP2000394979A
Publication Date:
August 14, 2001
Filing Date:
August 21, 1992
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
NPS PHARMACEUT INC
International Classes:
G01N33/15; A61K31/13; A61K31/135; A61K31/14; A61K31/16; A61K31/165; A61K31/235; A61K31/275; A61K31/395; A61K31/40; A61K31/403; A61K31/404; A61K31/44; A61K31/55; A61K31/554; A61K31/715; A61K31/785; A61K33/06; A61K38/00; A61K38/16; A61K45/00; A61P3/00; A61P3/14; A61P5/18; A61P5/22; A61P9/00; A61P9/12; A61P19/08; A61P19/10; A61P43/00; C07C211/02; C07C211/03; C07C211/15; C07C211/16; C07C211/17; C07C211/19; C07C211/26; C07C211/27; C07C211/29; C07C211/30; C07C211/42; C07C215/46; C07C215/48; C07C215/50; C07C215/52; C07C217/54; C07C217/56; C07C217/58; C07C217/60; C07C219/14; C07C225/16; C07C229/38; C07C233/05; C07C235/34; C07C235/44; C07C237/22; C07C237/30; C07C255/24; C07C255/45; C07C255/58; C07C279/14; C07C323/18; C07C323/32; C07D209/14; C07D209/16; C07D209/18; C07D209/30; C07D209/40; C07D211/90; C07D213/28; C07D213/36; C07D213/38; C07D215/12; C07D215/14; C07D233/54; C07D257/02; C07D281/10; C07D295/00; C07D413/04; C07H21/00; C07K5/00; C07K7/00; C07K14/435; C07K14/705; C08G69/10; C12N5/10; C12N15/09; C12N15/12; C12Q1/02; G01N33/50; G01N33/566; G01N33/567; G01N33/574; G01N33/68; G01N33/84; C12R1/91; A61K; G01N; (IPC1-7): A61K45/00; A61P3/14; A61P5/22; A61P9/12; A61P19/08; A61P19/10; A61P43/00; C12Q1/02
Attorney, Agent or Firm:
Reiko Tanaka (1 person outside)